CBT Pharmaceuticals Secures $9,750,000 Series A Financing
- Feed Type
- Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=2b73d05d-3874-496b-a365-9bef32296227 - Date
8/31/2016 - Company Name
CBT Pharmaceuticals - Mailing Address
3375 Scott Blvd. Santa Clara, CA 95054 USA - Company Description
CBT Pharmaceuticals is an emerging life sciences oncology company focused on developing innovative medicines targeting the growth and proliferation of cancer cells for which available treatments are inadequate. - Website
http://www.cbtpharma.com - Transaction Type
Venture Equity - Transaction Amount
$9,750,000 - Transaction Round
Series A - Proceeds Purposes
This financing allows us to advance two of our four development programs into human clinical trials. - M&A Terms
- Venture Investor
OrbiMed - Venture Investor
Undisclosed
